Peer Review History
| Original SubmissionAugust 2, 2025 |
|---|
|
Dear Dr. Patrick, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by Nov 20 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols . We look forward to receiving your revised manuscript. Kind regards, William M. Adams Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements 1.Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. When completing the data availability statement of the submission form, you indicated that you will make your data available on acceptance. We strongly recommend all authors decide on a data sharing plan before acceptance, as the process can be lengthy and hold up publication timelines. Please note that, though access restrictions are acceptable now, your entire data will need to be made freely accessible if your manuscript is accepted for publication. This policy applies to all data except where public deposition would breach compliance with the protocol approved by your research ethics board. If you are unable to adhere to our open data policy, please kindly revise your statement to explain your reasoning and we will seek the editor's input on an exemption. Please be assured that, once you have provided your new statement, the assessment of your exemption will not hold up the peer review process. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 4. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 5. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes Reviewer #2: Partly ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: Yes ********** Reviewer #1: 1) Your study combines glycerol with sodium bicarbonate (NaHCO₃) for hyperhydration, which you note has not been directly investigated before. Could you more explicitly highlight what new insights this combination provides compared to the well-studied glycerol + NaCl strategy? 2) How does your finding that G+SB accelerates fluid retention (but does not enhance peak retention compared to SB or G alone) advance the field in practical terms? For example, could this be positioned as a novel solution for athletes with limited pre-competition preparation time? 3) Could you clarify whether the novelty of your study lies primarily in the physiological insight (timing and buffering interactions) or in the applied context (sport, occupational use), and how this differs from prior work? 4) The study reports no changes in plasma volume despite significant differences in fluid retention. Could you elaborate on why plasma volume may not have reflected fluid retention differences, and whether methodological sensitivity may be a factor? 5) You used a glycerol dose (1.0 g·kg⁻¹ BM) that is lower than some prior studies. Could you justify this choice more explicitly in terms of expected efficacy versus GI tolerance, and whether higher doses might have altered the outcomes? 6) Since no additive benefit was observed in peak fluid retention for G+SB compared to single agents, do you think the practical advantage of G+SB is mainly about timing of onset? If so, would you recommend it over SB alone in competitive practice? 7) You note that GI symptoms were minimal across conditions. Could you provide more context on whether this is consistent with prior SB-only studies, where GI issues are often reported? What might explain the reduced severity in your cohort? Overall thoughts: This manuscript addresses an important and timely question regarding hyperhydration strategies in sport and occupational contexts, specifically the combined ingestion of glycerol and sodium bicarbonate. To my knowledge, this is the first study to directly examine the effects of this combination on fluid retention and blood buffering capacity, and the findings offer valuable practical insights for athletes competing in hot environments and situations where pre-event preparation time is limited. The study is well-designed, with a randomized crossover approach, clear methodology, and careful monitoring of hydration, buffering markers, and gastrointestinal symptoms. The results are robust, showing that both glycerol and sodium bicarbonate enhance fluid retention compared to control, and that the combination accelerates retention and enhances buffering capacity without worsening GI symptoms. These findings make a meaningful contribution to the literature on hydration strategies and performance support. Overall, I find the study scientifically sound, ethically conducted, and appropriately reported. With minor adjustments to data availability and interpretation, this manuscript will make a valuable addition to the literature and I recommend it for publication. Reviewer #2: In this study, investigators sought to assess the potential additive effects of sodium bicarbonate and glycerol on fluid retention and blood buffering parameters in physically active adults. Overall, fluid retention was increased with glycerol and sodium bicarbonate from 120-180 minutes post ingestion compared to control, promoting a slightly earlier time course for fluid retention compared to sodium bicarbonate and glycerol alone. This reviewer commends the authors for a well thought out study and offer the following recommendations to enhance the manuscript. Introduction: Line 72 add “and” before “increase plasma volume”. Remove the double citation block on line 76. It is unclear if it should be (7, 17) or (11-16). Remove double citation block in line 80. You can separate the paragraphs for each hyperhydration agent. The introduction could benefit from a brief discussion of the potential drawbacks of NaHCO3 on gastrointestinal distress, thereby supporting your decision to include this measurement. Methods Line 195 appears redundant to line 175-176 Line 205 – I recommend flipping the wording to make it clear that the subscript 0 refers to baseline, and subscript t refers to measurements at each subsequent timepoint, respectively. Lines 210-226 – You captured important information regarding menstrual cycle. Although you excluded days 1-3 of the menstrual cycle to minimize the influence of hormonal fluctuations on GI symptoms, was the ovulation test merely used to determine participants were not anovulatory? I am a little confused by the decision to only exclude this time rather than isolate to a specific phase, particularly when some of the authors of the study previously found a more pronounced increase in body mass in phase 4 of the menstrual cycle: https://pubmed.ncbi.nlm.nih.gov/39591960/ Line 246 – 250 – Rewrite this sentence for clarity; the second half can be omitted. Results Line 290 - why are both p>0.050 and the exact the p-values reported? The authors spend majority of the results discussing the difference between each beverage and the control condition. But the main effect of interest is any difference between G+SB and SB or G alone. It may be worth explicitly stating these null differences between experimental conditions in the results section as well. Discussion Line 366 – I believe it is overstating your conclusions to say glycerol and sodium induced hydration does not increase body mass. Greater fluid retention is evidence of an increase. Instead, I think it is more accurate to say the magnitude of the typical daily body mass fluctuations within each person was more variable than the observed between conditions differences in body mass change across different participants. But I do not believe it is accurate to say the glycerol and sodium does not increase body mass. If you examine the relative changes in body mass rather than the absolute number, I believe your results would align with the fluid retention values. Line 388-Good point about the time available before the race. Line 445 – This appears to be the incorrect reference number. ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No Reviewer #2: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org |
| Revision 1 |
|
Combined glycerol and sodium bicarbonate elicits improvements in fluid retention and blood buffering capacity PONE-D-25-35201R1 Dear Dr. Patrick, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support . If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, William M. Adams Academic Editor PLOS One Additional Editor Comments (optional): Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #1: All comments have been addressed Reviewer #2: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #1: Yes Reviewer #2: (No Response) ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: Yes Reviewer #2: (No Response) ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes Reviewer #2: (No Response) ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes Reviewer #2: (No Response) ********** Reviewer #1: The authors have answered all of my comments and I wish them good luck with the publishing of the manuscript! Reviewer #2: (No Response) ********** what does this mean? ). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: Yes: M AL RIZQI DHARMA FAUZI Reviewer #2: No ********** |
| Formally Accepted |
|
PONE-D-25-35201R1 PLOS One Dear Dr. Patrick, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. William M. Adams Academic Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .